Belvedere Trading LLC Annovis Bio, Inc. Call Options Transaction History

Belvedere Trading LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Nov 01, 2024	BUY	$4.82 - $18.01 $21,690 - $81,045	4,500 New	4,500 $25,000
Q2 2024 Aug 09, 2024	SELL	$4.82 - $18.01 $187,016 - $698,788	-38,800 Reduced 89.61%	4,500 $25,000
Q1 2024 May 09, 2024	BUY	$8.47 - $18.93 $146,531 - $327,489	17,300 Added 66.54%	43,300 $515,000
Q4 2023 Feb 13, 2024	BUY	$5.55 - $19.62 $144,300 - $510,120	26,000 New	26,000 $486,000

1.17M

229K

934K

Ticker ANVS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,163,920
Market Cap $48.7M
Description
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.